Toxophily Investments Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—4

Registered number: 15029086

		2026		2025
	Notes	£	£	£	£
FIXED ASSETS
Investment Properties	4		172,001		172,001

			172,001		172,001
CURRENT ASSETS
Debtors	5	46		208
Cash at bank and in hand		8,651		7,358

		8,697		7,566
Creditors: Amounts Falling Due Within One Year	6	(29 )		(421 )

NET CURRENT ASSETS (LIABILITIES)			8,668		7,145

TOTAL ASSETS LESS CURRENT LIABILITIES			180,669		179,146

Creditors: Amounts Falling Due After More Than One Year	7		(180,553 )		(177,322 )

NET ASSETS			116		1,824

CAPITAL AND RESERVES
Called up share capital	8		100		100
Profit and Loss Account			16		1,724

SHAREHOLDERS' FUNDS			116		1,824

Page 1

Page 2

Toxophily Investments Limited

Balance Sheet (continued)

As At 31 July 2026

For the year ending 31 July 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mrs Rosalyn Archer

Director

22/09/2026

The notes on pages 3 to 4 form part of these financial statements.

1. General Information

Toxophily Investments Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15029086 . The registered office is 2 Almond Tree Road, Wales, Sheffield, S26 5LB.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

Rendering of services

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Investment Properties

All investment properties are carried at fair value determined annually and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided for. Changes in fair value are recognised in the profit and loss account.

2.4. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 2 (2025: 2)

Page 3

Page 4

Toxophily Investments Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 July 2026

4. Investment Property

	2026
	£
Fair Value
As at 1 August 2025 and 31 July 2026	172,001

5. Debtors

	2026	2025
	£	£
Due within one year
Prepayments and accrued income	46	208

6. Creditors: Amounts Falling Due Within One Year

	2026	2025
	£	£
Corporation tax	-	404
Accruals and deferred income	29	17

	29	421

7. Creditors: Amounts Falling Due After More Than One Year

	2026	2025
	£	£
Directors' loan account	564	862
Amounts owed to associates	179,989	176,460

	180,553	177,322

8. Share Capital

	2026	2025
	£	£
Allotted, Called up and fully paid	100	100

9. Related Party Transactions

Archer Clinical Ltd

Associated Company

A company under the same control, Archer Clinical Ltd, has provided the company with a loan. The balance at the year end was £179,989 (2025 £176,460). The loan is unsecured and repayable on demand. Interest has been charged at 2% of the closing balance.

Rosalyn & Darren Archer

Directors

During the year the directors have provided a loan to the company. The balance at the year end was £564 (2025 : £862). The loan is unsecured, interest free and is repayable on demand.

10. Ultimate Controlling Party

The company's ultimate controlling party is Mrs Rosalyn Archer & Mr Darren Archer by virtue of their ownership of 100% of the issued share capital in the company.

Page 4